SonoThera: Funding, Investors & Team (Sep 2026)
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.
SonoThera has raised $186M across 2 funding rounds on record, the most recent a Series B of $125M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SonoThera Company Profile and Key Stats
Latest funding round on record: Jun 2026.
SonoThera Funding Rounds
SonoThera raised $60.8M in a Series A announced in Dec 2022.
3.5 years later, a Series B of $125M was announced in Jun 2026.
SonoThera Founders and Leadership Team
No contact details are on record for this team yet.
SonoThera Funding Compared to Other Biotechnology Startups
SonoThera's latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SonoThera in Biotechnology and San Francisco
Companies Similar to SonoThera
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
SonoThera Funding FAQs
What does SonoThera do?
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.
How much funding has SonoThera raised?
SonoThera has raised $186M across 2 rounds on record. The most recent is a Series B of $125M announced in Jun 2026.
When did SonoThera last raise funding?
SonoThera's most recent funding round on record is a Series B of $125M, announced in Jun 2026.
Who is the CEO of SonoThera?
Kenneth Greenberg is listed as CEO at SonoThera.
Where is SonoThera headquartered?
SonoThera is based in San Francisco, California, United States.
How many employees does SonoThera have?
SonoThera is in the 11-50 employee band.
How does SonoThera's funding compare to other Biotechnology startups?
SonoThera's latest round of $125M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's SonoThera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SonoThera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.